Subsequently, it was found that the expression levels of inflammatory factors such as transforming growth factor beta (TGF-β) IL-1, IL-6, IL-8, and IL-17 in peritoneal fluid, blood and endometriotic lesions differed between patients with and without EMs [11]. This evidence concerns the gene TGFB1 and eosinophilia-myalgia syndrome.